{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:23:49Z","timestamp":1784827429422,"version":"3.55.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002300","name":"Rivkin Center for Ovarian Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.canlet.2019.05.029","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T21:38:04Z","timestamp":1558647484000},"page":"92-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2\/STAT3 pathway"],"prefix":"10.1016","volume":"458","author":[{"given":"Kaitlin C.","family":"Fogg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will R.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamison N.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela K.","family":"Kreeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2019.05.029_bib1","first-page":"7","article-title":"Cancer statistics","volume":"66","author":"Siegel","year":"2016","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2019.05.029_bib2","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.canlet.2019.05.029_bib3","first-page":"CD007792","article-title":"Palliative surgery versus medical management for bowel obstruction in ovarian cancer","author":"Kucukmetin","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.canlet.2019.05.029_bib4","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/j.1440-1843.2012.02177.x","article-title":"Clinical implications of pleural effusions in ovarian cancer","volume":"17","author":"Porcel","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.canlet.2019.05.029_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/1049909114566225","article-title":"Malignant bowel obstruction in patients with recurrent ovarian cancer","volume":"33","author":"Tran","year":"2016","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.canlet.2019.05.029_bib6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10555-012-9351-2","article-title":"Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis","volume":"31","author":"Sodek","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2019.05.029_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2008.11.032","article-title":"Multicellular spheroids in ovarian cancer metastases: biology and pathology","volume":"113","author":"Shield","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2019.05.029_bib8","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1172\/JCI87252","article-title":"Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer","volume":"126","author":"Yin","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"37","key":"10.1016\/j.canlet.2019.05.029_bib9","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","article-title":"Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer","author":"Al Habyan","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2019.05.029_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-3163-6-11","article-title":"Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis","volume":"6","author":"Shield","year":"2007","journal-title":"J. Carcinog."},{"key":"10.1016\/j.canlet.2019.05.029_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.7785\/tcrt.2012.500312","article-title":"Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer","volume":"12","author":"Lan","year":"2013","journal-title":"Technol. Canc. Res. Treat."},{"key":"10.1016\/j.canlet.2019.05.029_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","article-title":"Distinct role of macrophages in different tumor microenvironments","volume":"66","author":"Lewis","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.029_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2019.05.029_bib14","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1039\/C3CC47507G","article-title":"A simplified culture system to examine soluble factor interactions between mammalian cells","volume":"50","author":"Carroll","year":"2014","journal-title":"Chem. Commun."},{"key":"10.1016\/j.canlet.2019.05.029_bib15","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1158\/0008-5472.CAN-17-3341","article-title":"Alternatively-activated macrophages upregulate mesothelial expression of P-selectin to enhance adhesion of ovarian cancer cells","volume":"78","author":"Carroll","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.029_bib16","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1089\/ten.tec.2015.0280","article-title":"Generation of homogenous three-dimensional pancreatic cancer cell spheroids using an improved hanging drop technique, tissue engineering","volume":"22","author":"Ware","year":"2016","journal-title":"Part C, Methods"},{"key":"10.1016\/j.canlet.2019.05.029_bib17","doi-asserted-by":"crossref","DOI":"10.1063\/1.5022595","article-title":"The extracellular matrix of ovarian cortical inclusion cysts modulates invasion of fallopian tube epithelial cells","volume":"2","author":"Fleszar","year":"2018","journal-title":"APL Bioengineering"},{"key":"10.1016\/j.canlet.2019.05.029_bib18","doi-asserted-by":"crossref","first-page":"86608","DOI":"10.18632\/oncotarget.13474","article-title":"M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor\/matrix metalloproteinase 9 intercellular feedback loop","volume":"7","author":"Carroll","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.05.029_bib19","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.3892\/mmr.2017.6538","article-title":"Interleukin 6 induces an epithelialmesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration","volume":"15","author":"Zhou","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2019.05.029_bib20","first-page":"275","article-title":"IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells","volume":"29","author":"Itoh","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.canlet.2019.05.029_bib21","doi-asserted-by":"crossref","first-page":"21100","DOI":"10.18632\/oncotarget.4228","article-title":"Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women","volume":"6","author":"Kato","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2019.05.029_bib22","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1021\/acs.jmedchem.5b01611","article-title":"Discovery of (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin- 1-yl)-2-(dimethylamino)ethanone (CHMFL-FLT3-122) as a potent and orally available FLT3 kinase inhibitor for FLT3-ITD positive acute myeloid leukemia","volume":"58","author":"Li","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2019.05.029_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nm.3411","article-title":"Regulatory T cell proliferative potential is impaired in human autoimmune disease","volume":"20","author":"Carbone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2019.05.029_bib24","first-page":"1270","article-title":"Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase\/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice","volume":"63","author":"Blaskovich","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.05.029_bib25","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ng.2762","article-title":"Emerging landscape of oncogenic signatures across human cancers","volume":"45","author":"Ciriello","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2019.05.029_bib26","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2019.05.029_bib27","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.celrep.2018.10.096","article-title":"Integrated genomic, epigenomic, and expression analyses of ovarian cancer cell lines","volume":"25","author":"Papp","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2019.05.029_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2019.05.029_bib29","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2019.05.029_bib30","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.4049\/jimmunol.1300058","article-title":"Cutting edge: flt3 ligand mediates STAT3-independent expansion but STAT3-dependent activation of myeloid-derived suppressor cells","volume":"192","author":"Rosborough","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2019.05.029_bib31","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2019.05.029_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/gyno.2001.6243","article-title":"Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer","volume":"82","author":"Lengyel","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2019.05.029_bib33","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2019.05.029_bib34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ygyno.2018.05.023","article-title":"An update on the use of immunohistochemistry and molecular pathology in the diagnosis of pre-invasive and malignant lesions in gynecological oncology","volume":"150","author":"Kalampokas","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2019.05.029_bib35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","article-title":"From monocytes to M1\/M2 macrophages: phenotypical vs. Functional differentiation","volume":"5","author":"Italiani","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2019.05.029_bib36","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1126\/science.1116598","article-title":"A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis","volume":"310","author":"Janes","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.canlet.2019.05.029_bib37","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.013292","article-title":"Cross-talk between receptor tyrosine kinase and tumor necrosis factor-alpha signaling networks regulates apoptosis but not proliferation","volume":"11","author":"Beyer","year":"2012","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.canlet.2019.05.029_bib38","doi-asserted-by":"crossref","first-page":"13855","DOI":"10.1038\/srep13855","article-title":"Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk","volume":"5","author":"Park","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2019.05.029_bib39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12935-015-0263-4","article-title":"High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation","volume":"15","author":"Bourgeois","year":"2015","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2019.05.029_bib40","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1517\/14728222.2014.926889","article-title":"Oncogenic role and therapeutic target of leptin signaling in colorectal cancer","volume":"18","author":"Zhou","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2019.05.029_bib41","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.mce.2013.03.025","article-title":"Leptin-cytokine crosstalk in breast cancer","volume":"382","author":"Newman","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.canlet.2019.05.029_bib42","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1158\/1535-7163.MCT-08-0417","article-title":"Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition","volume":"7","author":"Yagi","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2019.05.029_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11864-005-0018-x","article-title":"Rationale and clinical experience with epidermal growth factor receptor inhibitors in gynecologic malignancies","volume":"6","author":"Vaidya","year":"2005","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.canlet.2019.05.029_bib44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4161\/cbt.11.1.13877","article-title":"Prognostic effect of epidermal growth factor receptor gene mutations and the aberrant phosphorylation of Akt and ERK in ovarian cancer","volume":"11","author":"Tanaka","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2019.05.029_bib45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.18632\/genesandcancer.142","article-title":"EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review","volume":"8","author":"Mehner","year":"2017","journal-title":"Genes Cancer"},{"key":"10.1016\/j.canlet.2019.05.029_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2014-02-554667","article-title":"Impact of FLT3(ITD) mutant allele level on relapse risk in intermediate-risk acute myeloid leukemia","volume":"124","author":"Linch","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2019.05.029_bib47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1530\/ERC-11-0075","article-title":"Survivin upregulation, dependent on leptin-EGFR-Notch 1 axis, is essential for leptin-induced migration of breast carcinoma cells","volume":"18","author":"Knight","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.canlet.2019.05.029_bib48","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1038\/bcj.2011.43","article-title":"Pacritinib (SB1518), a JAK2\/FLT3 inhibitor for the treatment of acute myeloid leukemia","volume":"1","author":"Hart","year":"2011","journal-title":"Blood Canc. J."},{"key":"10.1016\/j.canlet.2019.05.029_bib49","first-page":"5772","article-title":"JAK2\/STAT3 pathway as a therapeutic target in ovarian cancers","volume":"15","author":"Yoshikawa","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.canlet.2019.05.029_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183622","article-title":"Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer","volume":"12","author":"Jia","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.05.029_bib51","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3892\/or.2011.1616","article-title":"Heparin-binding epidermal growth factor-like growth factor is a potent regulator of invasion activity in oral squamous cell carcinoma","volume":"27","author":"Ohnishi","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2019.05.029_bib52","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/cvr\/cvr275","article-title":"Leptin promotes the mobilization of vascular progenitor cells and neovascularization by NOX2-mediated activation of MMP9","volume":"93","author":"Schroeter","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.canlet.2019.05.029_bib53","first-page":"2750","article-title":"The anticancer effects of Cucurbitacin I inhibited cell growth of human nonsmall cell lung cancer through PI3K\/AKT\/p70S6K pathway","volume":"17","author":"Zhu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2019.05.029_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189670","article-title":"The JAK2\/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model","volume":"12","author":"Jensen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2019.05.029_bib55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/neuonc\/nos302","article-title":"On-target JAK2\/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells","volume":"15","author":"Stechishin","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2019.05.029_bib56","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/13543784.2017.1351941","article-title":"Do STAT3 inhibitors have potential in the future for cancer therapy?","volume":"26","author":"Wong","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.canlet.2019.05.029_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjy070","article-title":"A phase 2, randomized, placebo-controlled study evaluating matrix metalloproteinase-9 inhibitor, Andecaliximab, in patients with moderately to severely active crohn's disease","author":"Schreiber","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.canlet.2019.05.029_bib58","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1158\/1078-0432.CCR-17-2469","article-title":"Andecaliximab\/GS-5745 alone and combined with mFOLFOX6 in advanced gastric and gastroesophageal junction adenocarcinoma: results from a phase I study","volume":"24","author":"Shah","year":"2018","journal-title":"Clin. Cancer Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519303246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:44:55Z","timestamp":1759592695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519303246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":58,"alternative-id":["S0304383519303246"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.029","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2\/STAT3 pathway","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}